Important Updates! It was our Big Day of the 2023 AIM-HI Women’s Venture Competition this Wednesday. We are thrilled to announce the 6 Semi-Finalists this year, selected from a pool of 71 applications submitted by women-led, early-stage oncology companies from 15 different countries! Congratulations to these outstanding women entrepreneurs and their companies: Apeximmune Therapeutics |…
If AngeLink has a guardian angel, she may well be Dr. Sujuan Ba, Ph.D., who was recently featured as One of the 20 Most Inspiring Women Leaders of 2022 by The Women Leaders Magazine. “Sujuan believed in my vision for AngeLink before anyone else,” says AngeLink Founder and CEO Gerry Poirier. “She is the ‘definition’…
The AIM-HI Accelerator Fund is honored to be nominated for the 2022 Prix Galien USA Incubators, Accelerators and Equity Award. The newest Prix Galien Award category, “Incubators, Accelerators and Equity,” acknowledges the role played by organizations in guiding the next wave of innovators, by offering a range of mentoring skills including clinical trial design expertise,…
We’re excited that Dr. Sujuan Ba, AIM-HI CEO & Co-Founder, is featured as one of the “20 Most Inspiring Women Leaders 2022” by THE WOMEN LEADERS Magazine. Read about her illustrious career leading three successful non-profits in the field of cancer research, all the while paving the way for Women in Life Sciences. Her vision has…
Together, we can make the next generation of cancer treatments a reality.